- Home
- KROS vs DHC Comparison
KROS vs DHC Comparison
Compare KROS & DHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- DHC
- Stock Information
- Founded
- KROS 2015
- DHC 1998
- Country
- KROS United States
- DHC United States
- Employees
- KROS N/A
- DHC N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- DHC Real Estate Investment Trusts
- Sector
- KROS Health Care
- DHC Real Estate
- Exchange
- KROS Nasdaq
- DHC Nasdaq
- Market Cap
- KROS 460.6M
- DHC 629.7M
- IPO Year
- KROS 2020
- DHC N/A
- Fundamental
- Price
- KROS $11.00
- DHC $2.63
- Analyst Decision
- KROS Buy
- DHC Hold
- Analyst Count
- KROS 11
- DHC 3
- Target Price
- KROS $45.33
- DHC $4.50
- AVG Volume (30 Days)
- KROS 2.1M
- DHC 989.6K
- Earning Date
- KROS 02-26-2025
- DHC 02-25-2025
- Dividend Yield
- KROS N/A
- DHC 1.54%
- EPS Growth
- KROS N/A
- DHC N/A
- EPS
- KROS N/A
- DHC N/A
- Revenue
- KROS $651,000.00
- DHC $1,477,343,000.00
- Revenue This Year
- KROS $303.27
- DHC N/A
- Revenue Next Year
- KROS N/A
- DHC $4.46
- P/E Ratio
- KROS N/A
- DHC N/A
- Revenue Growth
- KROS 8037.50
- DHC 6.62
- 52 Week Low
- KROS $9.78
- DHC $2.01
- 52 Week High
- KROS $73.00
- DHC $4.24
- Technical
- Relative Strength Index (RSI)
- KROS 24.79
- DHC 67.74
- Support Level
- KROS $11.04
- DHC $2.39
- Resistance Level
- KROS $11.99
- DHC $2.50
- Average True Range (ATR)
- KROS 0.60
- DHC 0.13
- MACD
- KROS 1.20
- DHC 0.07
- Stochastic Oscillator
- KROS 43.99
- DHC 93.85
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About DHC Diversified Healthcare Trust of Beneficial Interest
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs.